GABAPENTIN
- Product NDC
- 81279-126
- 11-digit product format
- 812790126
- Labeler code
- 81279
- Product ID
- 81279-126_526cf9ed-8502-fed9-e063-6394a90adf42
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Pangea Pharmaceuticals, LLC
- Application
- ANDA219319
- Marketing category
- ANDA
- Marketing start
- 2026-05-22
- Substance
- GABAPENTIN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GABAPENTIN
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6CW7F3G59X |
| Rxcui | 2739001 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 81279-126-60 | GABAPENTIN | 60 in 1 BOTTLE | CAPSULE | 60 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 81279-126-60 | 81279012660 | 60 CAPSULE in 1 BOTTLE (81279-126-60) | 60 capsule | 2026-05-22 | No | No | Current |